Introduction {#sec1-1}
============

Poly(methyl vinyl ether-maleic acid) (PMVEMA) is a water-soluble, biodegradable polymer used for drug delivery.\[[@ref1]\] It is a typical polyanhydride polymer with great potential in biomedical application. It is well established that the maleic acid copolymers have a broad spectrum of biological activities which include antitumor activity, interferon inducing, wound healing and anti-inflammatory, antiviral, and antibacterial activities.\[[@ref2]\] Conjugation of this polymer to PEG and antisense oligonucleotides has been successfully used to treat inflammation and tumors in mouse models.\[[@ref1][@ref3]\] Moreover, it is used in encapsulation of calcitonin.\[[@ref4]\]

Fast-dissolving dosage forms are popular drug delivery systems due to their easy administration and fast onset of action. They rapidly release the drug in the buccal cavity and do not need any water to be swollen. These novel dosage forms may improve solubility/stability, biological half-life, and bioavailability of drugs. Among the oral fast-dissolving buccal dosage forms, the fast-dissolving tablets and films are more common, but the disadvantage of some of the tablets is the remained insoluble ingredients in the mouth that are unfavorable to be swallowed. However, the fast-dissolving films are advantageous over the tablets from this point of view.\[[@ref5][@ref6]\]

Montelukast is a CysLT~1~ antagonist, which binds to cysteinyl leukotriene receptor CysLT~1~ of the lungs and bronchial tubes and in this way blocks the effects of leukotriene D4. This mechanism alleviates the inflammation and bronchospasm in asthma.\[[@ref7]\] It is usually administered orally. To enhance the onset of action of this drug and fast sedation of the signs of allergy and bronchoconstriction of asthmatic patients, recently, fast-dissolving tablets \[[@ref8]\] and films \[[@ref9]\] of this drug have been developed. However, in both of them, it took at least 30 min to dissolve the drug. On the other hand, the very thin diameter and porous structure of nanofibers help the drug to have a more effective exit in the nanofibers than in films. The most famous and low cost method to build polymer nanofibers is electrospinning method.\[[@ref10]\]

Many polymeric electrospun nanofibers have been used so far for fast-dissolving buccal dosage forms. Among them are the electrospun polyvinyl-alcohol nanofibers for delivery of caffeine and riboflavin,\[[@ref11]\] polyvinylpyrrolidone nanofibers were also used as a fast-dissolving delivery system for paracetamol and caffeine,\[[@ref12]\] and sedative nanofibers of this polymer were also electrospun in a core-shell form by coaxial electrospinning technique.\[[@ref13]\]

The process of using electrostatic forces to form synthetic fibers has been known for over 100 years. Electrospinning process utilizes a high voltage source to inject an electric charge with a specific polarity to a polymer solution, where fibers accumulate on stacker surface with opposite polarity.\[[@ref14]\] Despite the relative ease of electrospinning, a number of processing parameters can greatly affect fiber formation and structure. These parameters include polymer concentration, applied voltage, polymer flow rate, and needle distance to the collector plate. In addition, all the four parameters can affect the formation of beads.\[[@ref14]\]

Therefore, we tried to use the PMVEMA polymer for production of fast-dissolving nanofibers for the first time since there is no report of its use in electrospinning.

In this regard, the aim of the present study was preparation of the nanofibrous mat by PMVEMA and loading them with montelukast to produce an antihistaminic and anti-inflammatory drug. This water-soluble polymer is biodegradable and biocompatible and has not been used so far for electrospinning of nanofibers, especially as a fast-dissolving drug delivery system.

Materials and Methods {#sec1-2}
=====================

Materials {#sec2-1}
---------

PMVEMA, dimethylformamide (DMF), and other reagents were purchased from Sigma Company (USA). Montelukast was provided by Morepen laboratory (New Delhi, India).

Electrospinning of nanofibers {#sec2-2}
-----------------------------

To optimize the processing parameters of electrospinning of nanofibers, a Taguchi design was used by Design expert software (Version 7.2, Stat-Ease, Inc. Minneapolis, MN 55413-2726, USA).

In the first stage, PMVEMA was dissolved in DMF at a concentration range of 35--39 w/v%, and different situations of electrospinning were examined to get the best conditions for obtaining nanofibers with the least beads and diameter. Solution injection speed was set between 1 and 0.2 ml/h, the voltage applied was 12--16 kV, and the needle distance to the rotating surface was 15--23 cm. The polymer solution was stirred for 20 h on a stirrer at 500 rpm. The final transparent solution was transferred to a 1 ml syringe attached to a 22-gauge needle. The final fibers were collected on an aluminum surface. All procedures were performed at 25°C. Different studied situations of the processing parameters are summarized in [Table 1](#T1){ref-type="table"}.
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After optimization of the processing parameters of electrospinning, the optimized nanofibers were prepared with 37% of PMVEMA containing 20% of montelukast (according to the polymer content), and the drug release test was carried out as the method mentioned in section 2.6.

Morphological studies of nanofibers {#sec2-3}
-----------------------------------

Nanofibers were coated with gold under vacuum in an argon atmosphere and their morphology was studied using a scanning electron microscope (SEM) (LEO 440i, UK) with magnification of (×600--1000k). The average fiber diameter of each sample was measured in the resulting image. In each image, at least 100 different points were randomly selected and their diameter was measured by Digimizer software (MedCalc Software bvba, Ostend, Belgium).\[[@ref15]\]

Fourier-transform infrared {#sec2-4}
--------------------------

The Fourier-transform infrared (FT-IR) spectra of selected samples were obtained using the FT-IR device (Perkin Elmer, Waltham, MA). Samples were prepared by potassium bromide (KBr) and scanned against a blank KBr disc at wave numbers ranging from 4000 to 450 cm^−1^ with a resolution of 1.0 cm^−1^.

Drug entrapment determination {#sec2-5}
-----------------------------

Drug loading percentage was identified by dissolving a sample piece (2.5 cm × 2.5 cm) of electrospun nanofibrous mat in DMF and measuring the absorbance at λ~max~= 284 nm spectrophotometrically (UV-mini 1240, Shimadzu, Kyoto, Japan). The concentration of montelukast in the solution was obtained using montelukast calibration curve in DMF. The drug loading percentage was calculated as follows:

Drug entrapment percentage = (weight of drug/the weight of the drug loaded web) × 100

*In vitro* drug release studies {#sec2-6}
-------------------------------

The mat of nanofibers was cut into pieces of 2.5 cm × 2.5 cm, and drug release was measured by immersing a certain weight of the mat in 10 ml of phosphate-buffered saline (at 7.4 pH) containing 0.5% Tween 20 under constant stirring at 300 rpm at 37°C. An equal amount of the free drug was also tested under the same conditions. At particular time intervals, a 50 μl sample of the release media was removed, and the concentration of the drug was measured using ultraviolet spectrophotometer at λ~max~= 237.5 nm. After each sampling, the same amount of fresh buffer was replaced in the release media. Each test was repeated in triplicate, and the mean values were reported.

Results {#sec1-3}
=======

Effect of processing variables on the diameter of nanofibers of poly(methyl vinyl ether-maleic acid) {#sec2-7}
----------------------------------------------------------------------------------------------------

Different processing conditions were studied and their impacts on the diameter of the nanofibers of this polymer were obtained. As shown in [Table 1](#T1){ref-type="table"}, the diameter size of nanofibers of PMVEMA varied between 400 and 1000 nm. Statistical analysis by ANOVA test followed by the least significant difference analysis showed a significant difference between all formulations (*P* \< 0.05) except for 5, 6, and 9.

[Table 1](#T1){ref-type="table"} summarizes that the applied voltage varied between 12 and 16 kV. The effect of changing the voltage on the diameter of nanofibers is shown in [Figure 1a](#F1){ref-type="fig"}. This figure depicts that decrease in the voltage reduced the nanofibers\' diameter size. At voltages of 14 and 16 kV, the fibers\' diameter did not change, but when the voltage reduced to 12 kV, the diameter reduced statistically significantly (*P* \< 0.05) \[[Table 1](#T1){ref-type="table"}\].

![Effect of (a) voltage, (b) flow rate, (c) distance of the needle to collector, and (d) concentration of poly(methyl vinyl ether-maleic acid) on the diameter of the electrospun nanofibers](ABR-7-84-g002){#F1}

Injection rate of the polymer solution was changed between 0.2 and 1 ml/h. According to [Figure 1b](#F1){ref-type="fig"}, by decreasing solution injection rate, the diameter of nanofibers reduced.

[Table 1](#T1){ref-type="table"} summarizes that the distance of the needle to the rotating plate was changed between 15 and 23 cm. [Figure 1c](#F1){ref-type="fig"} shows that the best distance for polymer fibers electrospinning which caused the least nanofiber diameter was 19 cm.

[Table 1](#T1){ref-type="table"} shows that the polymer concentrations used in this study were between 35 and 39 w/v%. [Figure 1d](#F1){ref-type="fig"} shows that, by reducing the concentration of PMEVMA, nanofiber size can also be reduced.

Finally, according to the Design Expert Software optimization, the best conditions for electrospinning of PMVEMA nanofibers were predicted to be at the concentration of 37%, distance of 19 cm, voltage of 12 kV, and injection rate of 0.2 ml/h. The nanofibers were electrospun at these conditions, and the average diameter size was measured to be 273 nm. [Figure 2](#F2){ref-type="fig"} depicts the SEM of these optimized nanofibers and also the other formulated nanofibers mentioned in [Table 1](#T1){ref-type="table"}.

![Scanning electron microscopy of all the formulated nanofibers of poly(methyl vinyl ether-maleic acid) and the optimized nanofibers electrospun at the optimum situation, i.e., polymer concentration of 37%, distance of 19 cm, voltage of 12 kV, and injection rate of 0.2 ml/h](ABR-7-84-g003){#F2}

To study the effect of the different concentrations of the drug on the diameter of the nanofibers, three different concentrations of the drug including 10%, 20%, and 30% were incorporated in the polymer solution and the fibers were electrospun at the optimum aforementioned situations, and the diameter of the fibers was determined. [Figure 3](#F3){ref-type="fig"} shows that incorporation of the higher concentrations of the drug resulted in growing of the fiber diameter due to enhanced viscosity of the electrospun solution.

![The effect of montelukast concentration on the diameter of poly(methyl vinyl ether-maleic acid) nanofibers](ABR-7-84-g004){#F3}

Montelukast loading percentage and release from the optimized nanofibers {#sec2-8}
------------------------------------------------------------------------

After optimization of the processing variables of electrospinning of PMVEMA nanofibers, the optimized nanofibers were loaded with 20% of montelukast (according to the polymer weight), and drug loading efficiency and its release profile were studied. The results showed that 83% of the applied drug was loaded in the nanofibers, and the total loaded drug was released immediately in \<3 s. The nanofibers were completely dissolved within this time and deteriorated completely. [Figure 4](#F4){ref-type="fig"} compares the dissolution profiles of the free montelukast and the loaded form of it in the optimized nanofibers.

![Drug release profiles from nanofibers of poly(methyl vinyl ether-maleic acid) containing 83% of montelukast in comparison to the free drug](ABR-7-84-g005){#F4}

Fourier-transform infrared spectroscopy {#sec2-9}
---------------------------------------

FT-IR spectra of free montelukast, PMVEMA, montelukast-loaded nanofibers, and blank nanofibers are depicted in [Figure 5](#F5){ref-type="fig"}. For free montelukast \[[Figure 5a](#F5){ref-type="fig"}\], the tertiary hydroxyl groups have exhibited a broad peak around 3300 cm−1 and a carboxylic acid peak which is in the form of a salt which has exhibited a strong peak near 1600 cm−1. Numbers of aromatic C-H peaks are also observed between 2900 and 3000 cm−1. In the spectrum of PMVEMA \[[Figure 5b](#F5){ref-type="fig"}\], a broad absorption band at 3420 cm−1 corresponds to the hydroxyl group of this polymer, and the absorption band at 1716 cm−1 is assigned to its carbonyl group. In both drug loaded and blank nanofibers \[Figure [5c](#F5){ref-type="fig"} and [d](#F5){ref-type="fig"}\], the characteristic peak of C = O which is seen at near 1700 cm−1 relates to the carboxylic acid groups of montelukast and PMVEMA, but absence of hydroxyl group around 3300--3500 cm−1 which was seen in the spectra of these substances probably indicates a strong hydrogen bonding between them in the nanofibers.

![Fourier-transform-infrared spectra of (a) free montelukast, (b) poly(methyl vinyl ether-maleic acid), (c) montelukast-loaded nanofibers, and (d) blank nanofibers](ABR-7-84-g006){#F5}

No beads were seen in the optimized nanofbers \[[Figure 2](#F2){ref-type="fig"}\]. At low concentrations, solvent molecules tend to congregate and create spherical bead shapes due to the low surface tension of the solvent. With an increase in concentration, the viscosity of the solution increases, which can transfer bending instabilities to a farther distance than the tip of the needle. Incorporation of the higher concentrations of montelukast in polymer solution resulted in growing of the fber diameter due to enhanced viscosity of the electrospun solution \[[Figure 3](#F3){ref-type="fig"}\]. The optimized nanofbers were loaded with 20% of montelukast (according to the polymer weight). The results showed that 83% of the applied drug was loaded in the nanofbers, and the total loaded drug was released immediately in \<3 s. The nanofbers were completely dissolved within this time and deteriorated completely \[[Figure 4](#F4){ref-type="fig"}\]. FTIR studies probably indicated a strong hydrogen bonding between PMVEMA and montelukast in the nanofbers \[[Figure 5](#F5){ref-type="fig"}\].

Discussion {#sec1-4}
==========

PMVEMA polymer is electrospun for the first time in this study. DMF and other solvents such as hexafluoro 2-propanol have been used as solvents for electrospinning of PLGA nanofibers.\[[@ref16][@ref17]\] DMF is a solvent with high dielectric constant (ε = 36.7) and has highly been regarded as a suitable solvent for electrospinning process.\[[@ref18]\] In the present study, this solvent was used as it could dissolve both components, i.e., PMVEMA and montelukast.

Different processing conditions were studied and their impacts on the diameter of the nanofibers of this polymer were obtained. The applied voltage varied between 12 and 16 kV. Decrease in the voltage reduced the nanofibers\' diameter size \[[Figure 1a](#F1){ref-type="fig"}\]. The applied voltage power controls the formation of nanofibers with diameters of a few microns to a few nanometers. Low voltage less than the optimal amount leads to the formation of beads in fibers or even jet is not formed. There is always an optimal range of voltage depending on the polymer system and solvent that can be neither too weak nor too strong.\[[@ref14]\] Deitzel *et al*.\[[@ref19]\] studied the nanofibers of polyethylene oxide (PEO) using water as the solvent. They showed that, by increasing the voltage level, Taylor-cone surface shape changed and jet fibers were formed. Meechaisue *et al*.\[[@ref20]\] applied different voltages to examine its effect on the structure of poly (desaminotyrosyl-tyrosine ethyl ester carbonate) nanofibers. They used voltages of 10--25 kV at a concentration of 15 w/v% of the polymer solution and observed that, in the voltages \<20 kV, beaded fibers were formed, whereas almost smooth fibers were obtained in voltages \>20 kV. Increase in voltage from 10 to 15 kV reduced the beads in the nanofibers, while increasing the voltage from 20 to 25 kV increased the fibers\' diameter from 1.9--2.2 μm.\[[@ref20]\]

By reducing the voltage and approaching the critical voltage, deceleration of jet and weaker electric field lead to an increase in the migration of the jet electrospinning. Longer migration time leads to applying stretching and elongation more before reaching the collector plate and thus reducing the fiber diameter.\[[@ref21]\]

Injection rate of the polymer solution is also effective on nanofibers\' diameter, size, and shape so that, by decreasing the solution injection rate, the diameter of nanofibers reduced \[[Figure 1b](#F1){ref-type="fig"}\]. It is well shown that when the fibers have enough time to dry before reaching a new fiber, they will be circular and have no beads, but fibers that do not dry well lead to the formation of wide ribbon-like fibers compared with circular cross-sectional fibers. Taylor showed that, if the rate of pass of solution from the needle is too much, the cone cannot stay at the tip of the needle.\[[@ref22]\] Megelski *et al*.\[[@ref23]\] examined the injection speed impact on polystyrene nanofiber structure in tetrahydrofuran (THF) solvent. They demonstrated that, when increasing the injection rate, fiber size increased. They changed the solution injection rate in the range of 0.004--0.24 ml/min. With an increase in flow rate, the diameter of nanofibers increased from 50 to 250 nm. At high speeds, a considerable number of beads were created because fibers did not dry well before reaching the collector.

The distance of needle tip to the rotating plate was another processing variable which was studied. Not only it is effective on the size of nanofibers, but also determines whether the final product is electrospun or electrosprayed.\[[@ref14]\] When the distance of the needle to the rotating plate was changed between 15 and 23 cm, the best distance was 19 cm \[[Figure 1c](#F1){ref-type="fig"}\] which caused the least nanofiber diameter. It becomes clear that this polymer has an optimal distance that, at distances greater or less than that, the diameter of the nanofiber increases.

Doshi and Reneker \[[@ref24]\] determined that, by increasing the distance, the fiber diameter decreases. In another study, Jaeger *et al*.\[[@ref25]\] prepared PEO nanofibers in water and examined the effect of distance. They found that, with increasing distance from 1 to 3.5 cm, diameter of the fibers declined from 19 to 9 μm. In addition, Megelski *et al*.\[[@ref23]\] showed that, over short distances, beads were created as the fibers did not dry well before reaching the collector plate. When they reduced the distance from 35 to 15 cm, the diameter of fibers increased from 70 to 200 nm. When spinning distance is reduced, fiber jet will have a shorter distance to reach the collector plate. In addition, the electric field strength increases and jet acceleration increases. As a result, there may not be enough time for evaporation of the solvent, in which case the thick fibers with beads are formed.

Polymer concentration determines the spinning of a solution, i.e., whether or not the fiber is formed. Solution should be thick enough to form fiber chain. However, the solution cannot be too thin or too thick. The polymer concentrations used in this study were between 35 and 39 w/v%. By reducing the concentration of PMEVMA, nanofiber size reduced \[[Figure 1d](#F1){ref-type="fig"}\]. Polymer concentration affects both viscosity and surface tension of the solution, both of which are very important parameters in the process of electrospinning. If the solution is too diluted, before reaching the collector, fibers are converted into drop due to low surface tension. However, if the solution is too thick, fibers cannot be formed due to high viscosity. Many studies have shown that, when increasing polymer concentration, the diameter of the fiber increases.\[[@ref14]\] Doshi and Reneker \[[@ref24]\] showed that, when the viscosity of the PEO solution in water is \<800 poise, they are sprayed as drops, while in viscosity above 4000 poise, it is so thick that it cannot be spun. Megelski *et al*.\[[@ref23]\] changed the polystyrene concentration from 18 to 35 w/v% in THF where the fiber diameter increased from 0.8 to 20 μ. They showed that, up to the concentration of 30% the fibers had beads, but more than that they were smooth.

At low concentrations, solvent molecules tend to congregate and create spherical and bead shapes due to the influence of low surface tension of the solvent.\[[@ref26]\] With increase in concentration, viscosity increases, which can transfer bending instabilities to a farther distance than the tip of the needle. As a result, the jet route decreases, and bending instability extend at a smaller level. This reduction in the jet route ends up in less stretch of the solution and more diameter of the fibers.\[[@ref27]\]

Conclusions {#sec1-5}
===========

Nanofibers of PMVEMA containing montelukast were successfully spun. Results for electrospinning of PMVEMA solution showed that, by reducing the voltage, injection rate of the solution, and concentration of the polymer, nanofibers\' size decreased. However, the variable of the distance between the tip of the needle to the rotating plate had a different effect on the diameter of the nanofibers. By reduction in the distance, initially, the nanofiber size decreased but then increased. Drug release from the optimized nanofibers was very fast and completed in \<3 s. The drug loading percentage was 83% in the nanofibers. The results of this preliminary study show that the PMVEMA nanofibers can be a good candidate for preparing the fast-dissolving buccal dosage form of montelukast. Further studies are needed to study the pharmacokinetic profiles of this dosage form in comparison to its conventional tablets.
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